Patents by Inventor Charles R. Bredl

Charles R. Bredl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7053096
    Abstract: Disclosed are compounds having selective hydrolytic potential. The disclosed compounds are useful as compounds having selective stability and are capable of undergoing programmed hydrolysis in biologic systems.
    Type: Grant
    Filed: May 5, 2004
    Date of Patent: May 30, 2006
    Assignee: Cell Therapeutics Inc.
    Inventors: David Porubek, Anil M. Kumar, Charles R. Bredl, J. Peter Klein
  • Publication number: 20040229836
    Abstract: Disclosed are compounds having selective hydrolytic potential. The disclosed compounds are useful as compounds having selective stability and are capable of undergoing programmed hydrolysis in biologic systems.
    Type: Application
    Filed: May 5, 2004
    Publication date: November 18, 2004
    Applicant: CELL THERAPEUTICS, INC.
    Inventors: David Porubek, Anil M. Kumar, Charles R. Bredl, J. Peter Klein
  • Patent number: 6780865
    Abstract: Disclosed are compounds having selective hydrolytic potential. The disclosed compounds are useful as compounds having selective stability and are capable of undergoing programmed hydrolysis in biologic systems.
    Type: Grant
    Filed: September 18, 1997
    Date of Patent: August 24, 2004
    Assignee: Cell Therapeutics, Inc.
    Inventors: David Porubek, Anil M. Kumar, Charles R. Bredl, J. Peter Klein